Efficacy of Carbapenems Compared With Noncarbapenem Broad-Spectrum Beta-Lactam Antibiotics as Initial Antibiotic Therapy Against Sepsis: A Nationwide Observational Study.

Umemura, Yutaka; Yamakawa, Kazuma; Tanaka, Yoshihiro; Yoshimura, Jumpei; Ogura, Hiroshi; Fujimi, Satoshi

Umemura, Yutaka; Yamakawa, Kazuma; Tanaka, Yoshihiro; Yoshimura, Jumpei; Ogura, Hiroshi; Fujimi, Satoshi.

Afiliación

Umemura Y; Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka, Japan.
Yamakawa K; Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Tanaka Y; Department of Emergency Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
Yoshimura J; Division of Epidemiology, Graduate School of Public Health, Shizuoka Graduate University of Public Health, Shizuoka, Japan.
Ogura H; Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Fujimi S; Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Crit Care Med ; 51(9): 1210-1221, 2023 09 01.

Article en En | MEDLINE | ID: mdl-37232855

Asunto(s)

Antibacterianos; Carbapenémicos; Sepsis; Adulto; Humanos; Antibacterianos/uso terapéutico; Carbapenémicos/uso terapéutico; Monobactamas; Combinación Piperacilina y Tazobactam/uso terapéutico; Estudios Retrospectivos; Sepsis/tratamiento farmacológico; Sepsis/mortalidad; Mortalidad Hospitalaria; Resultado del Tratamiento

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carbapenémicos / Sepsis / Antibacterianos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Crit Care Med Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google